Purchase Order 75N95022P00106
Award Date 2/1/22
Potential Completion Date 1/31/27
Potential Value $88K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Edgemoor, DE 19810, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $90,800.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Chemaxon LLC, a foreign-owned for-profit limited liability company. The contract, which has a completion date of September 29, 2023, is for the provision of ChemAxon software licenses, including JChem Oracle Cartridge, Marvin JS, JChem Base, and Instant JChem Enterprise. These specialized...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, has awarded a $1,785,000.00 firm fixed price purchase order contract to X-Chem, Inc., a for-profit drug discovery company. The 8-month contract, which runs from May 2023 through January 2024, does not have a set-aside designation. Based on X-Chem's prior work as a subcontractor on federal grants focused on early-stage drug discovery research, the contract likely...
- This sole source contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemaxon LLC is for annual license renewals of JChem Oracle Cartridge and Marvin JS software. Valued at $10,490, the firm fixed price contract provides 100 user licenses for both the JChem Oracle Cartridge and Marvin JS Library from July 1, 2023 through June 30, 2024 with an additional four 12-month option periods. The software licenses are...
- The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $26,870 sole-source purchase order to Caerus US 1 Inc., operating as Citeline, to provide five one-year licenses for its Biomedtracker database and five one-year licenses for the Enhanced Company Deals Upgrade. These software tools will support NCATS' work on intellectual property issues, patent filing, and industry partnerships by providing access to a comprehensive...
- The National Institute on Drug Abuse awarded a purchase order to Chemaxon LLC for JChem Oracle Cartridge and Marvin JS annual license renewals, with a ceiling value of $56,418.00 and an award date of July 1, 2024. The order covers two successive one-year periods: July 1, 2024 through June 30, 2025, and July 1, 2026 through June 30, 2027. Place of performance is Beverly, Massachusetts. The software licenses support NIDA's AIMS (ATDP Information Management System), enabling storage, search, and...
- This firm fixed-price federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), which is part of the U.S. Department of Health and Human Services, to Mestrelab Research SL, a software company based in Spain. The $7,926.30 contract provides user licenses, annual updates, and support for Mestrelab's Mnova software, which is used for analytical chemistry applications such as NMR, LC/GC/MS, and data management. The contract does not have a set-aside...
- Chemaxon LLC has been awarded a $23,865 firm fixed price purchase order by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide Chemaxon software licenses for use across the NIH's Protein Structure Prediction Pipeline and Enhanced Therapeutics Structure Prediction programs through September 2024. The licenses will support the NIH's efforts to advance understanding of neurological disorders and develop new treatments. As the prime contractor,...
- This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services (HHS), awarded a $206,440.00 firm-fixed-price purchase order to Schrodinger LLC, a subsidiary of Schrodinger, Inc., for the renewal of licenses for the Small Molecule Drug Discovery Suite software. This non-competitive award was made without a set-aside designation to Schrodinger, a leading provider of computational drug design solutions for the...
- This is a $103,500.00 firm fixed-price purchase order awarded by the National Library of Medicine (NLM), a civilian agency, to Xemistry GMBH, a foreign-owned for-profit organization, for the support and maintenance of the Xemistry CACTVS Chemoinformatics Toolkit used by the National Center for Biotechnology Information (NCBI). The award does not have a set-aside designation and the period of performance is from the award date of July 22, 2014 through the ultimate completion date of July 19,...